{{Rsnum
|rsid=8058532
|Gene=CDH13
|Chromosome=16
|position=83676061
|Orientation=plus
|GMAF=0.4991
|Gene_s=CDH13
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 22.1 | 44.2 | 33.6
| HCB | 35.8 | 51.1 | 13.1
| JPT | 39.8 | 44.2 | 15.9
| YRI | 10.9 | 40.8 | 48.3
| ASW | 7.0 | 42.1 | 50.9
| CHB | 35.8 | 51.1 | 13.1
| CHD | 39.4 | 50.5 | 10.1
| GIH | 19.8 | 54.5 | 25.7
| LWK | 10.9 | 37.3 | 51.8
| MEX | 50.0 | 37.9 | 12.1
| MKK | 4.5 | 34.6 | 60.9
| TSI | 28.4 | 45.1 | 26.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=2E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}